查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726187

自動注射器市場規模、佔有率、趨勢分析（按產品、適應症、最終用途、地區、細分市場預測），2025 年至 2030 年

Autoinjectors Market Size, Share & Trends Analysis By Product (Disposable, Reusable), By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes), By End-use (Home Care Settings, Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

自動注射器市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，全球自動注射器市場規模預計到2030年將達到206億美元，2025年至2030年期間的複合年成長率為15.1%。

隨著自動注射器核准的增加，過敏性休克、糖尿病、風濕病和多發性硬化症等疾病的發生率不斷上升，推動了自動注射器的成長。

預計危及生命的過敏症盛行率上升和對這些設備的需求增加將有助於這一成長。根據食物過敏研究和教育，每年約有 20 萬人因食物過敏反應而尋求緊急醫療照護。

此外，預計核准的增加將推動成長。例如，2018年8月，美國FDA核准了梯瓦製藥公司首個非專利腎上腺素自動注射器，用於治療緊急過敏反應，包括過敏性休克。 0.15 毫克Epipen Jr 和 0.3 毫克Epipen學名藥分別適用於體重 33 磅或以上的兒科患者和成人患者。

此外，製造商也在開發新產品和創新技術，預計這將推動市場成長。例如，2018年6月，日本艾伯維株式會社推出的全人源抗腫瘤壞死因子α單株抗體藥物Humira，不僅具有鎖定功能和注射開始/結束警報，還設有檢查窗口，並在10秒內完成注射。這些設備是根據患者的接受度和依從性設計的，因此需求正在增加。隨著技術的進步，預計它會變得更加方便和易於使用。這鼓勵患者採用這項技術治療慢性病。

自動注射器市場報告重點

  • 一次性自動注射器部分預計將在 2024 年佔據 56.8% 的最大市場佔有率，並在預測期內以最快的複合年成長率成長。可重複使用的自動注射器領域正在經歷顯著成長，這得益於患者對便利性和成本效益的偏好日益增加。
  • 2024 年，糖尿病領域佔了最大的市場佔有率，為 28.9%。預計多發性硬化症 (MS) 領域將在預測期內呈現最快的成長。
  • 預計到 2024 年，居家照護領域將佔據最大的收益佔有率，達到 54.1%，並且預計在預測期內將以最快的速度成長。預計醫院診所部門在預測期內也將顯著成長。
  • 北美汽車注射器市場將主導全球市場，到 2024 年將佔 45.3% 的收益佔有率。美國汽車注射器市場在 2024 年佔據北美汽車注射器產業的大部分佔有率。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章自動注射器市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 自動注射器市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章 自動注射器市場：依產品的評估與趨勢分析

  • 細分儀表板
  • 自動注射器市場：產品差異分析
  • 自動注射器市場產品前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 一次性自動注射器
  • 可重複使用的自動注射器

第5章自動注射器市場：依適應症的估計與趨勢分析

  • 細分儀表板
  • 自動注射器市場：適應症變異分析
  • 自動注射器市場前景（依適應症分類）
  • 2018-2030年市場規模、預測及趨勢分析
  • 類風濕性關節炎
  • 多發性硬化症
  • 糖尿病
  • 過敏反應
  • 其他

第6章 自動注射器市場：依最終用途的估算與趨勢分析

  • 細分儀表板
  • 自動注射器市場：最終用途差異分析
  • 自動注射器市場前景（按最終用途分類）
  • 2018-2030年市場規模、預測及趨勢分析
  • 居家照護
  • 醫院和診所
  • 門診手術中心

第7章 自動注射器市場：區域、估計與趨勢分析

  • 區域儀表板
  • 區域汽車注射器市場波動分析
  • 自動注射器市場：按產品、適應症和最終用途的區域估計和趨勢分析
  • 2018-2030年市場規模、預測及趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 市場參與企業分類
  • 2024年公司市場佔有率分析
  • 主要企業簡介
    • Eli Lilly
    • SHL Medical AG
    • AbbVie, Inc.
    • Amgen
    • Owen Mumford
    • Ypsomed
    • Teva Pharmaceutical
    • Biogen Idec
    • Mylan NV
    • Pfizer, Inc.
    • Sanofi
    • Gerresheimer AG
Product Code: GVR-3-68038-397-3

Autoinjectors Market Growth & Trends:

The global autoinjectors market size is expected to reach USD 20.6 billion by 2030, registering a CAGR of 15.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising incidence of anaphylactic shock and other diseases such as diabetes, rheumatoid, & multiple sclerosis along with increasing approvals of auto-injectors are impelling growth.

Increasing prevalence of life-threatening allergies and rising demand for these devices are expected to aid growth. As per the Food Allergy Research & Education, around 200, 000 people every year need emergency medical care for allergic food reactions.

In addition, increasing approvals are anticipated to drive growth. For instance, in August 2018, U.S. FDA approved the first generic epinephrine auto-injector of Teva Pharmaceuticals to treat emergency allergic reactions, including anaphylaxis. Generic versions of EpiPen Jr & EpiPen of 0.15 mg & 0.3 mg, respectively, are indicated for pediatric and adult patients weighing more than 33 pounds.

Moreover, manufacturers are also developing new products and innovative technologies, which is expected to propel market growth. For instance, in June 2018, AbbVie GK launched Humira, which is a fully human antitumor necrosis factor alpha monoclonal antibody formulation with lock function & injection start & end alerts as well as an inspection window and injects completely in 10 seconds. Demand for these devices is increasing as they are designed in accordance with patient acceptance and compliance. Technological advancements are anticipated to make them more convenient and user-friendly. This is encouraging patients to adopt this technology for chronic illnesses.

Autoinjectors Market Report Highlights:

  • The disposable autoinjectors segment accounted for the largest market share of 56.8% in 2024 and is expected to witness the fastest CAGR over the forecast period. The reusable auto injector segment is witnessing significant growth, driven by increasing patient preference for convenience and cost-effectiveness.
  • The diabetes segment accounted for the largest market share of 28.9% in 2024. The multiple sclerosis (MS) segment is expected to witness the fastest growth over the forecast period.
  • The homecare settings segment accounted for the largest revenue share of 54.1% in 2024 and is expected to witness the fastest growth over the forecast period. The hospitals and clinics segment is also expected to witness significant growth over the forecast period.
  • The North America autoinjectors market dominated the overall global market and accounted for the 45.3% revenue share in 2024. The autoinjectors market in the U.S. held a significant share of North America's auto-injectors industry in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.1. Segment Definitions
    • 1.1.1. Product
    • 1.1.2. Indication
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Indication outlook
    • 2.2.3. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Auto-Injectors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing prevalence of targeted therapies
      • 3.2.1.2. Increase in the incidence of anaphylactic shock
      • 3.2.1.3. Patients' preference to choose self-administration of injections
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Availability of its substitute products like general injections and oral tablets
  • 3.3. Auto-Injectors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Auto-Injectors Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Auto-Injectors Market: Product Movement Analysis
  • 4.3. Auto-Injectors Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Disposable Auto-Injectors
    • 4.5.1. Disposable Auto-Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Reusable Auto-Injectors
    • 4.6.1. Reusable Auto-Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.6.1.1. Prefilled Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.6.1.1.1. Prefilled Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.6.1.2. Empty Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.6.1.2.1. Empty Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Auto-Injectors Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Auto-Injectors Market: Indication Movement Analysis
  • 5.3. Auto-Injectors Market by Indication Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Rheumatoid Arthritis
    • 5.5.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Multiple Sclerosis
    • 5.6.1. Multiple Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Diabetes
    • 5.7.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Anaphylaxis
    • 5.8.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Other Therapies
    • 5.9.1. Other Therapies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Auto-Injectors Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Auto-Injectors Market: End Use Movement Analysis
  • 6.3. Auto-Injectors Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Homecare Settings
    • 6.5.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Hospitals & Clinics
    • 6.6.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Ambulatory Surgical Centers
    • 6.7.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Auto-Injectors Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Auto-Injectors Market movement analysis
  • 7.3. Auto-Injectors Market: Regional Estimates & Trend Analysis by Product, Indication & End Use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. UK Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Germany Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. France Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. Italy Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Spain Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Denmark
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Denmark Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Competitive Scenario
      • 7.6.8.3. Regulatory Framework
      • 7.6.8.4. Reimbursement scenario
      • 7.6.8.5. Sweden Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.9. Norway
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Competitive Scenario
      • 7.6.9.3. Regulatory Framework
      • 7.6.9.4. Reimbursement scenario
      • 7.6.9.5. Norway Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Japan
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Japan Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. China Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. India Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. South Korea Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.6. Australia
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Australia Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Thailand Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. Brazil
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Brazil Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Argentina Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Middle East & Africa
    • 7.9.1. Middle East & Africa Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.2. South Africa
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. South Africa Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. Saudi Arabia Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Competitive Scenario
      • 7.9.4.3. Regulatory Framework
      • 7.9.4.4. Reimbursement scenario
      • 7.9.4.5. UAE Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Competitive Scenario
      • 7.9.5.3. Regulatory Framework
      • 7.9.5.4. Reimbursement scenario
      • 7.9.5.5. Kuwait Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Share Analysis, 2024
  • 8.3. Key Company Profiles
    • 8.3.1. Eli Lilly
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. SHL Medical AG
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. AbbVie, Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Amgen
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Owen Mumford
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Ypsomed
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Teva Pharmaceutical
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Biogen Idec
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Mylan N.V.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Pfizer, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Sanofi
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Gerresheimer AG
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 5 Global auto-injectors market, by end use 2018 - 2030 (USD Million)
  • Table 6 North America auto-injectors market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 9 North America auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 12 U.S. auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Canada auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 18 Mexico auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe auto-injectors market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 22 Europe auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 24 UK auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 25 UK auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 27 Germany auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 28 Germany auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 30 France auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 31 France auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Italy auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 37 Spain auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Norway auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 39 Norway auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 40 Norway auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 43 Sweden auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 45 Denmark auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 46 Denmark auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific auto-injectors market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 52 Japan auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 53 Japan auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 54 China auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 55 China auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 56 China auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 58 India auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 59 India auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 62 Australia auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 64 South Korea auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 65 South Korea auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 68 Thailand auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America auto-injectors market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 72 Latin America auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Brazil auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 78 Argentina auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa auto-injectors market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 85 South Africa auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 91 UAE auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 94 Kuwait auto-injectors market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Auto-Injectors market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Auto-injectors market, type outlook key takeaways (USD Million)
  • Fig. 12 Auto-injectors market type movement analysis (USD Million), 2024 & 2030
  • Fig. 13 Disposable auto-injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Reusable auto-injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Prefilled market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Empty market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Auto-injectors market, indication outlook key takeaways (USD Million)
  • Fig. 18 Auto-injectors market indication movement analysis (USD Million), 2024 & 2030
  • Fig. 19 Rheumatoid arthritis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Multiple sclerosis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Diabetes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Anaphylaxis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Other therapies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Auto-injectors market, end use outlook key takeaways (USD Million)
  • Fig. 25 Auto-injectors market end use movement analysis (USD Million), 2024 & 2030
  • Fig. 26 Homecare settings market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Ambulatory surgical centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Auto-injectors market: Regional key takeaways (USD Million)
  • Fig. 30 Auto-injectors market regional outlook, 2024 & 2030, USD Million
  • Fig. 31 North America auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 UK auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Spain auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UAE auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 List of key emerging company's/indication disruptors/innovators